Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Regier

Showing results (201-210 of 301) with videos related to

Pageof 31
Sort By:
The American Journal of Psychiatry|November 1, 2012
DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5William E Narrow, Diana E Clarke, S Janet Kuramoto, et al.
BMC Cancer|June 19, 2026
Impact of precision oncology research in pediatric poor prognosis cancer: patient, parent and healthcare provider perspectivesN McCloskey, P Mahon, S R Rassekh, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 9, 2020
Heterogeneous Patient Preferences for Modern Antiretroviral Therapy: Results of a Discrete Choice ExperimentJan Ostermann, Axel Mühlbacher, Derek S Brown, et al.
JAMA|November 21, 1990
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) StudyD A Regier, M E Farmer, D S Rae, et al.
Psychiatric Services (Washington, D.C.)|July 16, 2013
Testing DSM-5 in routine clinical practice settings: feasibility and clinical utilityEve K Mościcki, Diana E Clarke, S Janet Kuramoto, et al.
The American Journal of Psychiatry|November 1, 2012
DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnosesDarrel A Regier, William E Narrow, Diana E Clarke, et al.
Drugs|March 1, 2005
An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonistsNick J Bansback, Dean A Regier, Roberta Ara, et al.
Psychiatry Research|February 1, 1987
Rapid dynamic CT scanning to distinguish schizophrenic from normal subjectsM Dysken, C S Patlak, G D Dobben, et al.
Archives of General Psychiatry|February 1, 1993
Progress toward achieving a common language in psychiatry. Results from the field trial of the clinical guidelines accompanying the WHO classification of mental and behavioral disorders in ICD-10N Sartorius, C T Kaelber, J E Cooper, et al.
The Journal of Nervous and Mental Disease|October 1, 1996
Prevalence of mental illness in Germany and the United States. Comparison of the Upper Bavarian Study and the Epidemiologic Catchment Area ProgramM M Fichter, W E Narrow, M T Roper, et al.
Pageof 31

Showing results (201-210 of 301) with videos related to

Sort By:
Pageof 31
The American Journal of Psychiatry|November 1, 2012
DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5William E Narrow, Diana E Clarke, S Janet Kuramoto, et al.
BMC Cancer|June 19, 2026
Impact of precision oncology research in pediatric poor prognosis cancer: patient, parent and healthcare provider perspectivesN McCloskey, P Mahon, S R Rassekh, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 9, 2020
Heterogeneous Patient Preferences for Modern Antiretroviral Therapy: Results of a Discrete Choice ExperimentJan Ostermann, Axel Mühlbacher, Derek S Brown, et al.
JAMA|November 21, 1990
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) StudyD A Regier, M E Farmer, D S Rae, et al.
Psychiatric Services (Washington, D.C.)|July 16, 2013
Testing DSM-5 in routine clinical practice settings: feasibility and clinical utilityEve K Mościcki, Diana E Clarke, S Janet Kuramoto, et al.
The American Journal of Psychiatry|November 1, 2012
DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnosesDarrel A Regier, William E Narrow, Diana E Clarke, et al.
Drugs|March 1, 2005
An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonistsNick J Bansback, Dean A Regier, Roberta Ara, et al.
Psychiatry Research|February 1, 1987
Rapid dynamic CT scanning to distinguish schizophrenic from normal subjectsM Dysken, C S Patlak, G D Dobben, et al.
Archives of General Psychiatry|February 1, 1993
Progress toward achieving a common language in psychiatry. Results from the field trial of the clinical guidelines accompanying the WHO classification of mental and behavioral disorders in ICD-10N Sartorius, C T Kaelber, J E Cooper, et al.
The Journal of Nervous and Mental Disease|October 1, 1996
Prevalence of mental illness in Germany and the United States. Comparison of the Upper Bavarian Study and the Epidemiologic Catchment Area ProgramM M Fichter, W E Narrow, M T Roper, et al.
Pageof 31